{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:04:57Z","timestamp":1790697897247,"version":"4.1.0"},"reference-count":10,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of VitreoRetinal Diseases"],"published-print":{"date-parts":[[2025,3]]},"abstract":"\n Purpose:<\/jats:bold>\n To describe the development of tractional retinal detachments (TRD) in a patient with diabetic retinopathy (DR) and a history of methamphetamine use.\n Methods:<\/jats:bold>\n A single case was evaluated.\n Results:<\/jats:bold>\n A 38-year-old man with type 2 diabetes mellitus presented to the clinic with worsening blurry vision in both eyes. A fundus examination, fundus photography, and optical coherence tomography were performed. The patient\u2019s bilateral TRDs were attributed to poorly controlled DR; thus, he was administered 1 intravitreal aflibercept injection in each eye and scheduled for surgery. His glycosylated hemoglobin A\n 1c<\/jats:sub>\n was only 6.3% and was controlled with metformin. In the interim, the patient was admitted for a stroke workup and diagnosed with Moyamoya disease and methamphetamine abuse.\n Conclusions:<\/jats:bold>\n In patients with underlying DR and presumed Moyamoya disease, TRDs can be exacerbated by methamphetamine use.\n <\/jats:p>","DOI":"10.1177\/24741264241302870","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T06:21:01Z","timestamp":1739600461000},"page":"257-261","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use"],"prefix":"10.1177","volume":"9","author":[{"given":"Angela J.","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Kentucky, Lexington, KY, USA"},{"name":"Retina Associates of Kentucky, Lexington, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3443-329X","authenticated-orcid":false,"given":"Omar","family":"Sabbagh","sequence":"additional","affiliation":[{"name":"West Virginia University, Morgantown, WV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Sabbagh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Kentucky, Lexington, KY, USA"},{"name":"Retina Associates of Kentucky, Lexington, KY, USA"},{"name":"Retina Group of Washington, Greenbelt, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Abou-Jaoude","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Kentucky, Lexington, KY, USA"},{"name":"Retina Associates of Kentucky, Lexington, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Kitchens","sequence":"additional","affiliation":[{"name":"Retina Associates of Kentucky, Lexington, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700197"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.490714"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/01658107.2016.1148174"},{"issue":"6","key":"e_1_3_2_5_2","first-page":"1008","article-title":"Moyamoya-like vasculopathy from cocaine dependency","volume":"21","author":"Storen EC","year":"2000","unstructured":"Storen EC, Wijdicks EF, Crum BA, Schultz G. Moyamoya-like vasculopathy from cocaine dependency. AJNR Am J Neuroradiol. 2000;21(6):1008-1010.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2020-000066"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-222883"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-009-9019-z"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)73979-0"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.107964"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2019.100473"}],"container-title":["Journal of VitreoRetinal Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264241302870","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/24741264241302870","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264241302870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:26:00Z","timestamp":1790695560000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/24741264241302870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/24741264241302870"],"URL":"https:\/\/doi.org\/10.1177\/24741264241302870","relation":{},"ISSN":["2474-1264","2474-1272"],"issn-type":[{"value":"2474-1264","type":"print"},{"value":"2474-1272","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]}}}